Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Membranous Glomerulonephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05800873
What this trial is testing

Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001

Who this might be right for
Primary Membranous Nephropathy
Everest Medicines (China) Co.,Ltd. 31
Post-approval studies (Phase 4)Study completedNCT01386554
What this trial is testing

Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients

Who this might be right for
ProteinuriaIdiopathic Membranous Nephropathy
Mallinckrodt 60
Not applicableUnknownNCT05861869
What this trial is testing

Clinical Trial of PLA2R-IgG4 Detection Kit (Time-resolved Fluorescence Immunoassay)

Who this might be right for
Membranous Nephropathy - PLA2R InducedKidney Diseases-except Membranous Nephropathy
Zhejiang Biostar Biotechnology Co. 450
Not applicableStudy completedNCT01845688
What this trial is testing

Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
wanglin 72
Not applicableLooking for participantsNCT05036850
What this trial is testing

China Kidney Patient Trials Network

Who this might be right for
Kidney Diseases
George (Beijing) Clinical Research Co. Ltd. 1,200
Not applicableNot Yet RecruitingNCT07785739
What this trial is testing

Clinical Prediction Model for Disease Progression in Primary Membranous Nephropathy

Who this might be right for
Membranous NephropathyNephrotic SyndromeKidney Diseases
Assiut University 128
Not applicableNot Yet RecruitingNCT07746453
What this trial is testing

Universal STAR-T Cell Injection in Autoimmune Kidney Diseases

Who this might be right for
IgA Nephropathy (IgAN)Primary Membranous Nephropathy
Guangdong Provincial People's Hospital 24
Not applicableUnknownNCT05532111
What this trial is testing

Efficacy and Safety of the Treatment of Primary Membranous Nephropathy: A Randomized Clinical Trial

Who this might be right for
Efficacy and Safety
RenJi Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00694863
What this trial is testing

Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Radboud University Medical Center 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04629248
What this trial is testing

A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Hoffmann-La Roche 142
Testing effectiveness (Phase 2)Study completedNCT04733040
What this trial is testing

Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE)

Who this might be right for
GlomerulonephritisMembranous NephropathyantiPLA2R Positive
HI-Bio, A Biogen Company 24
Large-scale testing (Phase 3)Study completedNCT01180036
What this trial is testing

MEmbranous Nephropathy Trial Of Rituximab

Who this might be right for
Idiopathic Membranous Nephropathy
Mayo Clinic 130
Large-scale testing (Phase 3)Looking for participantsNCT07163611
What this trial is testing

Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Study

Who this might be right for
Membranous Nephropathy - PLA2R Induced
Radboud University Medical Center 20
Early research (Phase 1)Looking for participantsNCT07266181
What this trial is testing

Safety and Efficacy of CD19 Chimeric Antigen Receptor T-Cell (CAR-T) in the Treatment of Refractory Membranous Nephropathy

Who this might be right for
Refractory Membranous Nephropathy
The First Affiliated Hospital of Air Force Medicial University 5
Very early researchNot Yet RecruitingNCT07535138
What this trial is testing

Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)IgA Nephropathy (IgAN)
Air Force Military Medical University, China 15
Not applicableStudy completedNCT02199145
What this trial is testing

Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy

Who this might be right for
Membranous Nephropathy
Centre Hospitalier Universitaire de Nice 52
Not applicableLooking for participantsNCT07516964
What this trial is testing

SLIT ABS: Study on Patients With Autoimmune Podocytopathy

Who this might be right for
Nephrotic Syndrome With Edema (Diagnosis)Minimal Change Nephrotic SyndromeFocal Segmental Glomerulosclerosis (FSGS)+1 more
Meyer Children's Hospital IRCCS 50
Early research (Phase 1)Looking for participantsNCT06285279
What this trial is testing

The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases

Who this might be right for
Lupus NephritisANCA-associated VasculitisMembranous Nephropathy - PLA2R Induced+1 more
Nanjing University School of Medicine 24
Not applicableLooking for participantsNCT01209000
What this trial is testing

Nephrotic Syndrome Study Network

Who this might be right for
Minimal Change Disease (MCD)Membranous NephropathyGlomerulosclerosis, Focal Segmental
University of Michigan 1,200
Not applicableLooking for participantsNCT07018024
What this trial is testing

Anti-Glomerular Basement Membrane Disease

Who this might be right for
Anti-Glomerular Basement Membrane Disease
Region Skane 300
Next Page